Clinical trial

Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder

NCT00373672

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-08-01

PhasePHASE4

Study timeline

Study start (unknown)2006-08-01Date precision: month

Registry last updated2025-08-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Schizoaffective Disorderunresolved

Interventions

armodafinil (Nuvigil)DRUG

placeboDRUG

Sponsors & collaborators

Northwestern Universitylead sponsor

National Alliance for Research on Schizophrenia and Depressioncollaborator

Cephaloncollaborator

Mapped research locations

NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00373672 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.